Chapter 60. Erythema Multiforme

  1. Hywel Williams MSC, PhD, FRCP Professor Dermato-Epidemiology Co-ordinating Editor
  1. Pierre-Dominique Ghislain MD1 and
  2. Jean-Claude Roujeau MD, PhD2

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300161.ch60

Evidence-Based Dermatology, Second Edition

Evidence-Based Dermatology, Second Edition

How to Cite

Ghislain, P.-D. and Roujeau, J.-C. (2008) Erythema Multiforme, in Evidence-Based Dermatology, Second Edition (ed H. Williams), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300161.ch60

Editor Information

  1. Centre of Evidence-Based Dermatology, Nottingham University Hospital NHS Trust, Queen's Medical Centre, Nottingham, UK

Author Information

  1. 1

    Cliniques Universitaires St-Luc, Service de Dermatologie, Brussels, Belgium

  2. 2

    Henri Mondor Hospital, University Paris XII, Créteil, France

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405145183

Online ISBN: 9781444300161



  • Erythema multiforme (EM) - acute, self-limited, feverish eruption;
  • acral lesions (palm);
  • systemic corticosteroids - short course of;
  • systemic acyclovir in recurrence prevention;
  • EM - low morbidity rate and no mortality;
  • spontaneous resolution and ocular sequelae;
  • corticosteroid influence on erythema multiforme major;
  • Levamisole and EM attack frequency - low risk–benefit ratio


This chapter contains sections titled:

  • Background

  • Questions

  • Summary

  • References